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Automated Office Blood Pressure Measurement for the
Diagnosis of Hypertension
A
ccurate blood pressure (BP) measurements are
important for the diagnosis and treatment of hyper-
tension in children and adolescents. Hypertension is
a significant risk factor for a number of chronic conditions
in children and adults, including cerebrovascular disease,
coronary artery disease, congestive heart failure, renal failure,
and stroke. Unfortunately, the prevalence of
pediatric hypertension has significantly
increased as a result of childhood obesity.1
Hypertension is routinely diagnosed using office BP mea-
surements, which should be interpreted using the Task Force
Office Blood Pressure reference thresholds guidelines.2-4 This
process requires knowledge of the patient’s height percentile.
There are a number of methods for BP measurements, and
we are about to learn that there now is another one which
may serve as an attractive alternative. The 4 most widely
used methods are conventional manual BP measurement
through the use of a sphygmomanometer (now rarely used
due to mercury concerns); an aneroid or oscillometric device
(often also named a digital device) in the clinic setting and
herein referred to as office BP; conventional BP measure-
ment, through the use of an aneroid or oscillometric device
outside of the clinic setting; arterial BP measurement, an
invasive method usually done in a hospital setting;
and ambulatory 24-hour BP monitoring (ABPM) using an
oscillometric device.
Office BP is used most often in the clinical setting. Howev-
er, one-third of children with office BP-based hypertension
also have white-coat hypertension, which does not require
treatment.5,6 Furthermore, office BP measurements are
insensitive to masked and nighttime hypertension, which
can independently influence end-organ damage.6,7
ABPM is used in clinical practice to better characterize
hypertension and to guide therapeutic decisions.5-7 This
method can diagnose white-coat, masked, and nighttime
hypertension. The American Academic of Pediatrics and
the European Society of Hypertension published guidelines
for the use of ABPM.2-4 There is also a version for Canada.8
Abnormal ABPM readings and confirma-
tion of end-organ damage serve as the gold
standard for the diagnosis of hypertension.
Although there are some differences when applying either
the American or European guidelines,9 all of them call for
the use of ABPM for the confirmation of hypertension.
Furthermore, routine ABPM is strongly recommended to
regularly assess severity and determine circadian BP patterns.
However, ABPM is not widely available because it involves
specialized instrumentation, trained staff, and other costs
that are nonreimbursable in many regions of the world. In
fact, reimbursement for ABPM varies widely among the
different states in the US and in Canada. Another limitation
is the frequent need for shipment of the ABPM monitor at
cost for the hospitals, which is not reimbursed. Moreover,
wearing the ABPM monitor for 24 hours is not convenient
for small patients andmay explain the significant intrapatient
variability of ABPM in the pediatric setting.10 As such, an
abbreviated version of automated BP monitoring would be
desirable.
In this volume of The Journal, Coral Hanevold et al de-
scribes a novel study that determined the level of agreement
between automated office BP (AOBP), auscultated (manual)
office BP, and ABPM to correctly identify hypertension in pa-
tients less than 18 years of age.11 Hanevold et al introduced us
to a fifth method, and it is essentially the measurement of BP
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by an automated device, without staff assistance, in an effort
to address the limitations of the standard office BP, decrease
the white coat effect, and approximate the ABPM readings.
Hanevold’s group analyzed automated office AOBP mea-
surements from 2016 to 2018 using the BpTRU device
(BpTRU Medical Devices Ltd, Coguitlam, British Colombia,
Canada); which has been validated for children. This device
has 6 automated office AOBP measurements programmed
by factory settings and Hanevold’s group discarded the first
one, to average the remaining five readings. In children
<13 years of age, daytime ambulatory hypertension was diag-
nosed if mean BPs were ³95th percentile and BP loads were
³25%. In children ³13 years of age, ABPM thresholds for
daytime hypertension of 130/80 mm Hg were used.11 To
ensure adequacy of the ABPMs, the authors used the number
of measurements specified in the 2014 American Heart Asso-
ciation criteria.
Hanevold’s group described 187 patients with or without
hypertension, regardless of BP treatment. Of these, 120
patients had a rest period and 67 had no rest period. The ma-
jority of patients were adolescents, but 52 were <13 years of
age. Patients were predominantly male. In the majority of
cases, ABPM, manual office BP, and automated office BP
were done on the same day. On ABPM, 32% of patients
had hypertension. Indeed, the authors found that automated
office BP was slightly more accurate in correctly identifying
hypertension (65% agreement) than manual office BP
(58% agreement). The best overall agreement was seen if
both manual office BP and automated office BP showed hy-
pertension (70%); however, sensitivity was low. Specificity
was better if both AOBP andmanual office BP showed hyper-
tension and in children under 13 years of age, it was 86%. The
authors also performed a detailed analysis using adult thresh-
olds for the older children. Finally, they assessed the percent-
age of correct classification and concluded that 49% of
patients with hypertension would be misclassified. Their final
conclusion was that ABPM has an ongoing role in the evalu-
ation of hypertension in children and for now, it cannot be
replaced by AOBP.
This study adds important new evidence about the use of
automated office BP in the pediatric setting.11 Although these
preliminary findings may be discouraging, they compel us to
consider evaluating this method further. Automated office BP
is recommended for adults by Hypertension Canada and sup-
ported for adults by the American Heart Association and the
European Society of Hypertension.12-14 The study by Hane-
vold et al suggests a limited role for automated office BP in
children, but thismethodmay have an important role in iden-
tifying patients better suited for the scarcely available ABPM,
especially because the combination of office BP and auto-
mated office BP seems to identify patients with hypertension
more correctly than office BP alone, which may substantially
decrease the need for ABPM to confirm hypertension.
Although the retrospective study by Hanevold et al repre-
sents a description of a real-world clinical experience, it also
provides empirical evidence that calls for the need to do a
multicenter, prospective study of children suspected to
have hypertension. This retrospective study included patients
with hypertension and one consideration would be to start
with treatment-na€ıve patients, who have all measurements
done on the same day. Data could be stratified by age, sex,
and validated standardized body mass index z-scores (partic-
ularly in morbidly obese children, where the World Health
Organization criteria could be applied.) The standard defini-
tions for elevated office BP readings could be those described
by the 2017 pediatric criteria by Flynn et al and the 2014
ABPM guidelines led by the same author with consideration
for the number and kind of devices.2 The setup also has to be
given some consideration, because a number of children need
a caregiver in the room, so standardizing this methodology
would decrease the introduction of bias. Comparisons by
the number of BP readings as well as systolic and diastolic dif-
ferences would need to be included. For the routine workflow
in the clinics, a determination of the minimum number of
measurements that yields the best predictive classification
of hypertension would be ideal. Alternating the first reading
method (manual readings vs automated device) also would
need to be considered.
Unfortunately, manufacturers of ABPM machines have
not agreed on any standardization, compared with what we
have for creatinine (isotope-dilution mass spectrometry
traceability) and for cystatin C (international certified refer-
ence materials).15,16 ABMP machine manufacturers do not
even share the algorithms for the calculation of the systolic
and diastolic BP. We need consistent certification of ABPM
machines for children and standardized programs with
appropriate reference intervals. The undersigned believe
that there may be value to include a feature for automated of-
fice BP for all ABPM machines that are certified for children,
because the ideal program (ie, number of measurements, dis-
carding of the first measurement, interval of repeat measure-
ments) has yet to be determined. It is also necessary to
advocate for reimbursement of the testing, especially because
guidelines call for the routine use of ABPM in patients with
chronic kidney disease.
We would like to mention a cross-sectional survey
among the Canadian Pediatric Nephrology centers in
terms of the adherence to guideline recommendations
(unpublished results, Filler G, Fall 2019).8 We noted that
72.7% of centers cannot provide the test to all patients with
chronic kidney disease for various reasons that include the
number of machines available and reimbursement of all asso-
ciated costs. Only 27.3% of centers stated that they can
accommodate the recommendation of the new American
Academy of Pediatrics guidelines.2 In Canada, most centers
use the aging Spacelab 90207 model, presumably because it
has published reference intervals.17,18 However, all the cen-
ters have the ability and trained personnel to perform
ABPM. Mostly, the machines are privately funded through
foundations, and in all but 2 provinces there is no reimburse-
ment. In the Canadian provinces where there is reimburse-
ment, the amounts fall short of that for similar tests such as
a Holter monitor. It seems that most of the provinces made
no contribution to funding and maintaining the emerging
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standard of ABPM for the diagnosis and monitoring of hy-
pertension. The majority of centers seem to have insufficient
resources to confirm the diagnosis of hypertension, which
raises the concern that patients with white coat hypertension
may have received unnecessary treatment.19 Automated of-
fice BP in combination with office BP may aid with a more
judicious selection of ideal patients for ABPM.
Automated office BP (especially when combined with of-
fice BP) may be a feasible tool to strategically and sparingly
use the scarce resource of ABPM for the diagnosis of hyper-
tension. Although Hanevold et al feel that neither office BP
nor AOBP accurately diagnose daytime hypertension, the
combination of both methods may improve the identifica-
tion of patients who need ABPM.11We encourage continuing
research into automated office BP for the identification and
treatment of hypertension. Hanevold et al should be congrat-
ulated for their contribution and the ongoing efforts to
improve the diagnosis and management of hypertension in
children. n
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